Despite advances in maternal healthcare, Peripartum Cardiomyopathy (PPCM) remains a significant cause of maternal morbidity and mortality globally, with mortality rates still reaching 10% to 20%. (1) Recent
data indicate that up to 25% of patients with PPCM develop chronic heart failure. (2) Is there a need to do more to protect mothers during one of their most vulnerable times?

The editorial aims to raise awareness about PPCM, highlight the latest research on its risk factors and pathophysiology, and advocate for improved screening and early intervention to reduce its burden on maternal health. Addressing these gaps is important for ensuring better outcomes for mothers worldwide.